Oklahoma researchers develop new MRSA antiiobiotic treatment
by Press Release from Outbreak News Today on (#1EHB3)
A University of Oklahoma team of chemists has developed a new antibiotic formulation to fight the sometimes deadly staph infection caused by methicillin-resistant S. aureus or MRSA and other antibiotic-resistant infectious bacteria. The new drug to treat MRSA combines traditional Food and Drug Administration-approved antibiotics, such as methicillin, with the polymer BPEI. Charles Rice, principal ["]
